Targeting Neuroinflammation to Treat Alzheimer's Disease.

A, Ardura-Fabregat; EWGM, Boddeke; A, Boza-Serrano; S, Brioschi; S, Castro-Gomez; K, Ceyzériat; C, Dansokho; T, Dierkes; G, Gelders; MT, Heneka; L, Hoeijmakers; A, Hoffmann; L, Iaccarino; S, Jahnert; K, Kuhbandner; G, Landreth; N, Lonnemann; PA, Löschmann; RM, McManus; A, Paulus; K, Reemst; JM, Sanchez-Caro; A, Tiberi; der Perren A, Van; A, Vautheny; C, Venegas; A, Webers; P, Weydt; TS, Wijasa; X, Xiang; Y, Yang

doi:10.1007/s40263-017-0483-3

Public

Targeting Neuroinflammation to Treat Alzheimer's Disease.

Shared by NobleBlocks on Dec 1, 2017 • 12:00 AM UTC

Authors:

Ardura-Fabregat A

Boddeke EWGM

Boza-Serrano A

Abstract

Over the past few decades, research on Alzheimer's disease (AD) has focused on pathomechanisms linked to two of the major pathological hallmarks of extracellular deposition of beta-amyloid peptides and intra-neuronal formation of neurofibrils. Recently, a third disease component, the neuroinflammato...

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!